Corvitin is a soluble form of quercetin (QUE) and its effects are based on the ability to inhibit the activity of 5-lipoxygenase and to block the formation of leukotrienes. Corvitin increases bloodflow inE nzyme 5-lipoxygenase (5-LO) plays an essential role in the biosynthesis of leukotrienes (LTs). Leukotriene LTB4 is a potent chemotactic and chemokinetic agent for a variety of leukocytes, while cysteinyl leukotrienes C4, D4 and E4 regulate vascular permeability and smooth muscle contraction. These compounds have vasoconstrictor properties and cause prolonged increased pressure in large blood vessels and capillaries. Inhibitors of LT synthesis have been hypothesized to possess therapeutic potential for the treatment of asthma, allergic disorders and other diseases [1]. Physiological effects of LTs on the liver are not stu died enough. It was shown that the addition of LTD4 to liver perfusate resulted in a decrease of portal blood flow, bile flow and bile acids (BAs) release [2,3]. Specific blockers of 5LO activity do not affect the synthesis of other arachidonic acid metabolites -prostaglandins and thromboxane [4].Formation of bile by hepatocytes is an important way of removing potentially harmful exogenous © 2017 Vovkun T. V. et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. lipophilic substances and endogenous compounds such as bilirubin and cholesterol [5]. Bile contains ВAs, which are synthesized in the liver from cholesterol. These molecules ensure the stability of bile colloidal system, dispersion and absorption of dietary fats in the intestine, activation of pancreatic lipase, intensification of intestinal motility [6].Plant polyphenol quercetin (QUE) attracts attention due to a wide range of positive effects on human health including hepatoprotective effect [7]. But its impact on bile formation and secretion has not been studied. It is known that QUE effects depend on applied doses, redox status of target cells and metabolites synthesis [8]. Despite the high effectiveness of QUE its bioavailability is very low. This complicates the investigation of QUE effects in vivo. In this study we used a water-soluble form of QUE corvitin at different doses. Corvitin is the inhibitor of 5LO, it is natural compound without side effects, that has been used to treat cardiac disorders [9]. Previously we found that this flavonoid modulates gastric sedoi: https://doi.org/10.15407/ubj89.05.106